Role of Nanoemulsified Sesame Oil in Post-operative Care After Endoscopic Sinus Surgery
Launched by MANSOURA UNIVERSITY · May 25, 2024
Trial Information
Current as of March 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient age between 18 and 60 years old.
- • 2. chronic rhinosinusitis patients who have undergone endoscopic sinus surgery.
- Exclusion Criteria:
- • 1. Patients with history of allergy for sesame seed derivatives.
- • 2. Patients with chronic diseases which affecting the process of healing (uncontrolled DM, renal failure and hepatic failure).
- • 3. Patients with nasal granulomas.
- • 4. Patients with invasive fungal rhinosinusitis.
- • 5. Smokers.
- • 6. Patients with history of radio and/or chemotherapy exposure.
- • 7. Patients with systemic diseases affecting integrity of nasal mucosa (e.g. CF, scleroderma, Sjogren syndrome ...).
About Mansoura University
Mansoura University is a prestigious academic institution located in Egypt, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, it leverages its extensive resources and expertise in various fields of healthcare to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a network of healthcare professionals and researchers to conduct high-quality clinical trials, focusing on addressing critical health challenges through rigorous scientific methodologies. Its dedication to ethical research practices and adherence to regulatory standards underscores its role as a leader in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mansoura, Dakahliya, Egypt
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
